[Cryoablation of endometrium in the treatment of pathological metrorrhagia]

Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-11 ⓘ

This paper reviews cryoablation as a minimally invasive method for destroying the endometrium to treat pathological metrorrhagia in women without anatomical anomalies or malignancies who do not desire future fertility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

It is assumed that pathological metrorrhagia means blood loss amounting to above 80 ml in one menstrual cycle in women without diagnosed anatomical anomalies of uterus. Pathological metrorrhagia is the reason for hospitalization of many women. At present two methods are used in the treatment of this disorder: hormonotherapy and destruction of endometrium. Destruction of endometrium can be performed in case of irregular metrorrhagia in women with excluded malignant neoplasm (on the basis of intake of samples for histopathologic examination) and in women who do not wish to have children any more. There are various methods of endometrium destruction: thermal ablation, microwave ablation, laser ablation and cryoablation. All above mentioned methods are deemed so-called "minimally invasive methods".

My notes (saved in your browser only)

MeSH descriptors

Cryosurgery Metrorrhagia Metrorrhagia Minimally Invasive Surgical Procedures Cryosurgery Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Hyperplasia Female Humans Metrorrhagia Metrorrhagia Minimally Invasive Surgical Procedures

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:37.664955+00:00
License: CC0 · commercial use OK